Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients
Μaria Anastasiou(National and Kapodistrian University of Athens), Dimitris Tousoulis(National and Kapodistrian University of Athens), Maria Gazouli(National and Kapodistrian University of Athens), Gerasimos Siasos(Brigham and Women's Hospital), Konstantinos Kalogeras(National and Kapodistrian University of Athens), Flora Zagouri(National and Kapodistrian University of Athens), Panagiotis Theofilis(General Hospital of Nikea), Alkistis Papatheodoridi(National and Kapodistrian University of Athens), Athina Goliopoulou(National and Kapodistrian University of Athens), Amanda Psyrri(National and Kapodistrian University of Athens), Evangelos Oikonomou(National and Kapodistrian University of Athens), Stavroula Lygkoni(National and Kapodistrian University of Athens), Theodoros Pesiridis(National and Kapodistrian University of Athens)
Cited by 19
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618